| Name | 1-(2-Thenoyl)-4-methylthiosemicarbazide |
|---|
| Description | KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C7H9N3OS2 |
|---|---|
| Molecular Weight | 215.30 |
| Exact Mass | 215.01900 |
| PSA | 113.49000 |
| LogP | 1.65950 |